3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
22
Observational
3
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Cardiovascular Diseases
2
Cardiotoxicity
2
Neoplasms
1
Metabolic Syndrome
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Heart Failure
1
Cardiomyopathies
1
Interventions
Blood Specimen Collection
131
Surveys and Questionnaires
130
Specimen Handling
57
Observation
55
Radiotherapy
44
Interviews as Topic
34
Surgical Procedures, Operative
32
Drug Therapy
31
Biopsy
28
Data Collection
26
Magnetic Resonance Spectroscopy
25
Nivolumab
20
Watchful Waiting
20
Immune Checkpoint Inhibitors
18
Immunotherapy
17
Magnetic Resonance Imaging
17
Therapeutics
17
Standard of Care
16
trastuzumab deruxtecan
14
Liquid Biopsy
13
Tomography, X-Ray Computed
13
palbociclib
13
Hematologic Tests
12
Restraint, Physical
12
Focus Groups
11
Genetic Testing
11
Bevacizumab
10
Positron Emission Tomography Computed Tomography
10
darolutamide
10
enzalutamide
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Electrocardiography
×
1 year
×
Clear all
NCT06605833
2025-10-01
CARD-IO
Royal Marsden NHS Foundation Trust
Enrolling by invitation
60 enrolled
NCT05201014
2025-09-05
CASCADE
Mayo Clinic
Active not recruiting
112 enrolled
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled